The nation of Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for sensitive biological samples.
This move came to light after a official document from December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson later clarified that the US was demanding access to genetic material for scientific study and commercial purposes while was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued talks to find a deal suitable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
This development follows a similar case in Kenya, where a court halted a related deal with the US after concerns were raised about the safety of Kenyans' medical information.
After resuming office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and accountability.
Based on reports, Sixteen African countries have so far signed similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our population if a new disease outbreak arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending structures already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to ongoing discussions with our US partners on how subsequent co-operation could be arranged in a manner that respects the sovereignty and interests of each country."
Health Experts Response
A leading public health body said it recognised the government's concerns, but suggested that negotiations must proceed since a large portion of the country's HIV programmes were funded by international support.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group said.
The situation emphasises the ongoing challenges between receiving crucial international aid and protecting local interests in an increasingly interconnected world.